Yaotang (Shanghai) Biotechnology Co Ltd
Yaotang (Shanghai) Biotechnology Co Ltd
03/07/2026 | Press release | Archived content
YolTech to Present at Keystone Symposia
YolTech Therapeutics will participate in the upcoming Keystone Symposia, a globally recognized scientific conference series that brings together leading researchers from academia, industry, and government to discuss cutting-edge advances in life sciences and biomedical research.
Dr. Yuxuan Wu, Co-Founder and Chief Executive Officer of YolTech Therapeutics, has been invited to present at the conference, sharing the company's latest progress in in vivo gene-editing technologies.
Date: March 12, 2026
Time: 8:00 AM (MDT)
Session: Therapeutic Application
Venue: Van Horne A, Fairmont Banff Springs, Banff, Alberta, Canada
Presentation: Design of Therapeutic Editors Aided by AI and High Throughput Approaches
For more details, see the program: Keystone Symposia Program
Yaotang (Shanghai) Biotechnology Co Ltd published this content on March 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 30, 2026 at 04:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]